Folgen
Axel Bex
Axel Bex
The Netherlands Cancer Institute Amsterdam
Bestätigte E-Mail-Adresse bei nki.nl
Titel
Zitiert von
Zitiert von
Jahr
EAU guidelines on renal cell carcinoma: 2014 update
B Ljungberg, K Bensalah, S Canfield, S Dabestani, F Hofmann, M Hora, ...
European urology 67 (5), 913-924, 2015
27702015
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Escudier, C Porta, M Schmidinger, N Rioux-Leclercq, A Bex, V Khoo, ...
Annals of Oncology 30 (5), 706-720, 2019
11932019
European association of urology guidelines on renal cell carcinoma: the 2019 update
B Ljungberg, L Albiges, Y Abu-Ghanem, K Bensalah, S Dabestani, ...
European urology 75 (5), 799-810, 2019
10092019
Epidemiology of renal cell carcinoma
U Capitanio, K Bensalah, A Bex, SA Boorjian, F Bray, J Coleman, JL Gore, ...
European urology 75 (1), 74-84, 2019
8372019
Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy
L Marconi, S Dabestani, TB Lam, F Hofmann, F Stewart, J Norrie, A Bex, ...
European urology 69 (4), 660-673, 2016
4692016
Guidelines on renal cell carcinoma
B Ljungberg, K Bensalah, A Bex, S Canfield, S Dabestani, F Hofmann, ...
European association of urology 2013, 2013
4652013
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical …
A Bex, P Mulders, M Jewett, J Wagstaff, JV Van Thienen, CU Blank, ...
JAMA oncology 5 (2), 164-170, 2019
3372019
Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions
JA Nieuwenhuijzen, RR de Vries, A Bex, HG van der Poel, W Meinhardt, ...
European urology 53 (4), 834-844, 2008
3322008
Local treatments for metastases of renal cell carcinoma: a systematic review
S Dabestani, L Marconi, F Hofmann, F Stewart, TBL Lam, SE Canfield, ...
The Lancet Oncology 15 (12), e549-e561, 2014
3002014
European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European Association of Urology guidelines …
MJ Ribal, P Cornford, A Briganti, T Knoll, S Gravas, M Babjuk, C Harding, ...
European urology 78 (1), 21-28, 2020
2282020
Male‐to‐female transsexualism: A technique, results and long‐term follow‐up in 66 patients
S Krege, A Bex, G Lümmen, H Rübben
BJU international 88 (4), 396-402, 2001
2192001
Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues
D Hameyer, A Loonstra, L Eshkind, S Schmitt, C Antunes, A Groen, ...
Physiological genomics 31 (1), 32-41, 2007
1992007
Sunitinib for treatment of advanced renal cell cancer: primary tumor response
AAM Van der Veldt, MR Meijerink, AJM van den Eertwegh, A Bex, ...
Clinical Cancer Research 14 (8), 2431-2436, 2008
1962008
Critical appraisal of the PADUA classification and assessment of the RENAL nephrometry score in patients undergoing partial nephrectomy
MN Hew, B Baseskioglu, K Barwari, PH Axwijk, C Can, S Horenblas, ...
The Journal of urology 186 (1), 42-46, 2011
1942011
Updated European Association of Urology Guidelines: recommendations for the treatment of first-line metastatic clear cell renal cancer
T Powles, L Albiges, M Staehler, K Bensalah, S Dabestani, RH Giles, ...
European urology 73 (3), 311-315, 2018
1922018
Tumour-specific proline vulnerability uncovered by differential ribosome codon reading
F Loayza-Puch, K Rooijers, LCM Buil, J Zijlstra, J F. Oude Vrielink, ...
Nature 530 (7591), 490-494, 2016
1922016
Updated European Association of Urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell …
L Albiges, T Powles, M Staehler, K Bensalah, RH Giles, M Hora, ...
European urology 76 (2), 151-156, 2019
1762019
Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience
BK Kroon, S Horenblas, W Meinhardt, HG van der Poel, A Bex, ...
European urology 47 (5), 601-606, 2005
1762005
Systemic treatment of metastatic clear cell renal cell carcinoma in 2018: current paradigms, use of immunotherapy, and future directions
AKA Lalani, BA McGregor, L Albiges, TK Choueiri, R Motzer, T Powles, ...
European urology 75 (1), 100-110, 2019
1682019
Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell CarcinomaAntiangiogenic Therapy Increases PD-L1 …
XD Liu, A Hoang, L Zhou, S Kalra, A Yetil, M Sun, Z Ding, X Zhang, S Bai, ...
Cancer immunology research 3 (9), 1017-1029, 2015
1612015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20